»óºÎ ¿ä·Î»óÇǼ¼Æ÷¾ÏÁ¾¿¡¼ TwistÀÇ ¹ßÇöÀÌ È¯ÀÚÀÇ ¹«º´ »ýÁ¸¿¡ ¹ÌÄ¡´Â ¿µÇâ ¹× Á¾¾ç µî±Þ°úÀÇ ¿¬°ü¼º
wist Expression in Upper Urinary Tract Urothelial Carcinoma Affects Patients Disease Free Survival and is Associated with Tumor Grade
±èµ¿ÀÏ, ¹®°æö, À±¼±¿Á, ±èº¸¹Ì, °°æÈÆ, ¹Ú¼®¿¬,
¼Ò¼Ó »ó¼¼Á¤º¸
±èµ¿ÀÏ ( Kim Dong-Il )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹®°æö ( Moon Kyung-Chul )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
À±¼±¿Á ( Yoon Sun-Och )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èº¸¹Ì ( Kim Bo-Mi )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
°°æÈÆ ( Kang Gyeong-Hoon )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Ú¼®¿¬ ( Park Seog-Yun )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
KMID : 0357920070410050324
Abstract
Background : Epithelial-mesenchymal transition (EMT) is critical for morphogenesis during embryonic development and is also implicated in the conversion of early-stage tumors into invasive malignancies.
Recently, Twist has been identified to play an important role in EMT-mediated metastatic progression of several types of human cancer. The present study examined the expression of Twist and evaluated its clinicopathologic significance in urothelial carcinoma of upper urinary tract.
Methods : Immunohistochemical staining for Twist expression was performed on 70 upper urinary tract urothelial carcinomas (UUT-UCs) using tissue microarray.
Results : Immunohistochemical staining for Twist was positive in 31/70 cases (44.3%) of UUT-UCs. Twist expression was associated with high-grade and advanced-stage (ISUP grade, p<0.01; stage, p=0.045). The patients with Twist positive-tumors revealed lower disease free survival rate than those with Twist negative-tumors (p<0.01). The overall survival for patients with Twist positive-tumors was slightly worse than the patients with Twist negative-tumors, but the difference was not statistically significant (p=0.12).
Conclusion : Our results suggest that Twist is a novel marker for advanced UUT-UC.
Å°¿öµå
Carcinoma;transitional cell;Twist transcription factor;Disease free survival
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸